Biden announces international COVID-19 vaccine-sharing plan
President Biden announced Thursday the U.S. will donate 75% of its unused COVID-19 vaccines to the U.N.-backed COVAX global vaccine-sharing program, acting as more Americans have been vaccinated and global inequities have become more glaring.
Of the first tranche of 25 million doses, the White House said about 19 million will go to COVAX, with approximately 6 million for South and Central America, 7 million for Asia and 5 million for Africa.
The doses mark a substantial — and immediate — boost to the lagging COVAX effort, which to date has shared just 76 million doses with needy countries.
Overall, the White House aims to share 80 million doses globally by the end of June, most through COVAX. But 25% of the nation’s excess will be kept in reserve for emergencies and for the U.S. to share directly with allies and partners.
“As long as this pandemic is raging anywhere in the world, the American people will still be vulnerable,” Biden said in a statement. “And the United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home.”
U.S. national security advisor Jake Sullivan said the U.S. “will retain the say” on where the doses distributed through COVAX ultimately go.
“We’re not seeking to extract concessions, we’re not extorting, we’re not imposing conditions the way that other countries who are providing doses are doing; we’re doing none of those things,” Sullivan said. “These are doses that are being given, donated free and clear to these countries, for the sole purpose of improving the public health situation and helping end the pandemic.”
Researchers in South Africa have documented an ominous development: the collision of the COVID-19 pandemic with HIV/AIDS.
The remaining 6 million in the initial tranche of 25 million will be directed by the White House to U.S. allies and partners, including Mexico, Canada, South Korea, West Bank and Gaza, India, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq and Yemen, as well as for United Nations frontline workers.
Vice President Kamala Harris informed some U.S. partners they will begin receiving doses, in separate calls with Mexican President Andres Manuel López Obrador, President Alejandro Giammattei of Guatemala, Indian Prime Minister Narendra Modi and Prime Minister Keith Rowley of Trinidad and Tobago. Harris is to visit Guatemala and Mexico in the coming week.
The long-awaited vaccine-sharing plan comes as demand for shots in the U.S. has dropped significantly — more than 63% of adults have received at least one dose — while most other countries struggle.
Scores of countries have requested doses from the United States, but to date only Mexico and Canada have received a combined 4.5 million doses.
The U.S. also has announced plans to share enough shots with South Korea to vaccinate its 550,000 troops who serve alongside American service members on the peninsula. White House COVID-19 coordinator Jeff Zients said that 1 million Johnson & Johnson doses were being shipped to South Korea on Thursday.
The growing U.S. stockpile of COVID-19 vaccines is seen by many overseas and at home not only as a testament to America’s achievement but also its global privilege.
Tom Hart, acting chief executive of the ONE Campaign, called the Thursday announcement a “welcome step” but said the Biden administration needs to commit to sharing more doses. “The world is looking to the U.S. for global leadership and more ambition is needed.”
The world’s failure to deliver vaccines to needier countries is more than a scandal; it’s a crisis. And it could come to haunt us all soon.
Biden has committed to providing other nations with all 60 million domestically produced doses of the AstraZeneca vaccine, which has yet to be authorized for use in the U.S. but is widely used around the world. The U.S.-produced doses have been held up for export by an ongoing safety review by the Food and Drug Administration, Zients said.
The White House says the initial 25 million doses will be shipped from existing federal stockpiles of Pfizer, Moderna and Johnson & Johnson vaccines. More doses are expected to be made available to share in the months ahead.
As part of its purchase agreements with drug manufacturers, the U.S. controlled the initial production by its domestic manufacturers. Pfizer and Moderna are only now starting to export vaccines produced in the U.S. to overseas customers. The U.S. has hundreds of millions more doses on order, both of authorized and in-development vaccines.
The White House also announced Thursday that it was lifting restrictions on sharing the vaccines produced by Sanofi and Novavax, which are also not authorized in the U.S., allowing the companies to determine for themselves where to share their doses.
Get our Essential Politics newsletter
The latest news, analysis and insights from our politics team.
You may occasionally receive promotional content from the Los Angeles Times.